Early research (Phase 1)Study completedNCT00058812
What this trial is testing
Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Who this might be right for
Epstein-Barr Virus Infections
Baylor College of Medicine 69